SCHEMBL6655852

SCHEMBL6655852

CC(C)CC(Nc1nc(=O)oc2ccccc12)C(=O)NC1(C#N)CC1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSL P07711 17/20 0.54
CTSS P25774 7/20 0.52
CTSK P43235 7/20 0.52
CTSB P07858 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493922 0.84 CTSS (0.52) CTSLCTSSCTSKCTSB
SCHEMBL6836920 0.83 CTSL (0.40) CTSLCTSSCTSKCTSB
SCHEMBL6836041 0.82 CTSS (0.42) CTSLCTSSCTSKCTSB
SCHEMBL8256796 0.81 CTSS (0.44) CTSLCTSSCTSKCTSB
SCHEMBL6832872 0.81 CTSL (0.39) CTSLCTSSCTSKCTSB
SCHEMBL6836731 0.81 CTSL (0.39) CTSLCTSSCTSKCTSB
SCHEMBL6836712 0.80 CTSL (0.38) CTSLCTSSCTSKCTSB
SCHEMBL7685576 0.80 CTSL (0.38) CTSLCTSSCTSKCTSB
SCHEMBL5366750 0.80 CTSS (0.53) CTSLCTSSCTSK
SCHEMBL14383686 0.80 CTSS (0.53) CTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434769-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2004-07-07 EP claimed
WO-2003029200-A2 COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2003-04-10 WO claimed